M3, Inc. (TYO:2413)
Japan flag Japan · Delayed Price · Currency is JPY
1,697.50
+82.50 (5.11%)
Aug 14, 2026, 3:30 PM JST

M3, Inc. Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
355,268351,363284,900238,883230,818208,159
Revenue Growth
15.76%23.33%19.26%3.49%10.88%23.03%
Gross Profit
179,749175,844154,364140,531135,186123,268
Operating Income
68,98070,68062,06665,63870,41567,364
Net Income
46,14349,10040,48445,27149,02863,845
Earnings Per Share
68.0972.5059.6066.6372.1793.98
EPS Growth
12.58%21.64%-10.55%-7.68%-23.21%68.79%

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Medical Platform Segment
108,141107,83091,56693,41493,09885,928
Evidence Solution Segment
23,99324,52124,24426,70027,15722,756
Career Solution Segment
22,51822,79920,91416,64214,53814,094
Site Solution Segment
55,51654,35347,04333,02535,29535,184
Patient Solution Segment
58,20756,87721,919---
Overseas Segment
88,94486,92180,57069,86862,09551,831
Other Emerging Businesses Segment
2,2172,2302,4532,6333,2843,360
Adjustments to Segment
-4,268-4,168-3,809-3,399-4,649-4,994

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
-156,177134,933149,661118,319104,253
Total Debt
-60,49451,41731,78310,3828,297
Net Cash (Debt)
-95,68383,516117,878107,93795,956
Net Cash Growth
-14.57%-29.15%9.21%12.49%19.76%
Net Cash Per Share
-141.29122.96173.49158.89141.25

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-70,26251,74358,31057,11352,108
Capital Expenditures
--7,680-6,290-5,412-5,911-1,705
Free Cash Flow
-62,58245,45352,89851,20250,403
Free Cash Flow Growth
-37.69%-14.07%3.31%1.58%11.03%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
50.59%50.05%54.18%58.83%58.57%59.22%
Operating Margin
19.42%20.12%21.79%27.48%30.51%32.36%
Pretax Margin
21.18%21.71%22.74%28.82%32.20%46.21%
Profit Margin
12.99%13.97%14.21%18.95%21.24%30.67%
FCF Margin
-17.81%15.95%22.14%22.18%24.21%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
22.00022.00021.00021.00019.00016.000
Dividend Per Share Growth
4.76%4.76%0%10.53%18.75%33.33%
Dividend Yield
1.30%1.37%1.25%1.01%0.60%0.37%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
24.9321.8228.5532.0545.7147.51
Forward PE
20.5520.3123.5327.1543.5854.03
P/FCF Ratio
18.1017.1225.4327.4343.7760.18
PS Ratio
3.193.054.066.079.7114.57